v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Parenthetical)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
USD ($)
Payments to Acquire Businesses, Net of Cash Acquired $ (6,500) [1]
Proceeds from Secured Notes Payable 1,025 [2],[3]
Proceeds From Issuance Of Debt Equity Securities (4,397)
Registered Direct [Member]  
Issuance expenses $ 529
[1] Represents cash acquired in connection with the acquisition of Oratech from Oramed Pharmaceuticals Inc., a related party, of $6,500.
[2] Represents proceeds from issuance of Additional Notes to Oramed Pharmaceuticals Inc., a related party, of $1,025 for the three months ended March 31, 2026.
[3] See Note 9 to the condensed consolidated financial statements.